found that the expression of hsa-mir-148 family decreased in AML patients, and it was highly correlated with FAB typing of AML (44).They also verified that DNMT1 was identified to be a downstream target of hsa-mir-148, and was negatively regulated by miR-148a in AML cell lines. The gene discussed is DNMT1; the disease is acute myeloid leukemia.